Is NRC or UHS cheaper?

On trailing earnings, UHS is cheaper: NRC trades at a 52.33 P/E and UHS at 6.11.

Which has grown faster, NRC or UHS?

Over the past five years, UHS grew revenue faster — NRC at a 0.55% CAGR versus UHS at 8.63%.

Does NRC or UHS pay a bigger dividend?

NRC yields 3.08% and UHS yields 0.55% based on trailing dividends and the latest price.

Is NRC or UHS more profitable?

UHS runs the higher net margin — NRC at 6.52% versus UHS at 8.56%.

Which has been the better investment, NRC or UHS?

Over the past 10-year, NRC delivered the higher annualized total return — NRC at 6.34% versus UHS at 1.10%. Past performance doesn't predict future results.

National Research Corporation (NRC) vs Universal Health Services, Inc. (UHS)

UHS leads on 12 of 16 compared metrics.

A side-by-side comparison of National Research Corporation and Universal Health Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 27, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

NRC

National Research Corporation

$469M

$20.81Healthcare

UHS

Universal Health Services, Inc.

$9.12B

$145.69Healthcare

Total return — NRC vs UHS

growth of $100 · last 13y

NRC +4.0%UHS +117.4%UHS compounded faster

NRC UHS

NRC vs UHS: by the numbers

•UHS is the larger company ($9.12B vs $469M market cap).
•UHS trades at the lower earnings multiple (6.11 vs 52.33 P/E).
•UHS converts more revenue to profit (8.56% vs 6.52% net margin).
•UHS grew revenue faster over the past five years (8.63% vs 0.55% CAGR).
•NRC pays the higher dividend yield (3.08% vs 0.55%).

Which is better, NRC or UHS?

Metric tally: NRC 4 · UHS 12

It depends on what you're optimizing for:

ValueUHS(lower P/E)

GrowthUHS(faster 5Y revenue CAGR)

IncomeNRC(higher dividend yield)

QualityNRC(higher ROIC)

Metrics side by side

Valuation

Metric	NRC	UHS
P/E ratio	52.33	6.11●
Forward P/E	23.65	6.21●
P/S ratio	3.29	0.51●
P/B ratio	33.79	1.19●
PEG ratio	—	0.26
EV / EBITDA	19.11	5.25●
FCF yield	3.82%	9.94%●

Profitability

Metric	NRC	UHS
Gross margin	55.85%	90.45%●
Operating margin	14.11%●	11.50%
Net margin	6.52%	8.56%●
ROE	66.94%●	20.19%
ROIC	14.36%●	11.29%

Dividends

Metric	NRC	UHS
Dividend yield	3.08%●	0.55%
Payout ratio	123.08%	3.42%

Growth (annualized)

Metric	NRC	UHS
Revenue CAGR (5Y)	0.55%	8.63%●
EPS CAGR (5Y)	-18.88%	16.19%●
FCF CAGR (5Y)	-17.24%	-4.64%●
Total return CAGR (5Y)	-12.81%	-0.22%●

Frequently asked

Which is better, NRC or UHS?: It depends on your goal. value: UHS (lower P/E); growth: UHS (faster 5Y revenue CAGR); income: NRC (higher dividend yield); quality: NRC (higher ROIC). Across all compared metrics, UHS leads 12 to 4.
Is NRC or UHS cheaper?: On trailing earnings, UHS is cheaper: NRC trades at a 52.33 P/E and UHS at 6.11.
Which has grown faster, NRC or UHS?: Over the past five years, UHS grew revenue faster — NRC at a 0.55% CAGR versus UHS at 8.63%.
Does NRC or UHS pay a bigger dividend?: NRC yields 3.08% and UHS yields 0.55% based on trailing dividends and the latest price.
Is NRC or UHS more profitable?: UHS runs the higher net margin — NRC at 6.52% versus UHS at 8.56%.
Which has been the better investment, NRC or UHS?: Over the past 10-year, NRC delivered the higher annualized total return — NRC at 6.34% versus UHS at 1.10%. Past performance doesn't predict future results.

Go deeper

Full NRC analysis Full UHS analysis Interactive comparison tool

Dig into the metrics

National Research P/E ratio Universal Health Services P/E ratio National Research dividend yield Universal Health Services dividend yield National Research ROE Universal Health Services ROE National Research operating margin Universal Health Services operating margin National Research revenue growth Universal Health Services revenue growth National Research free cash flow Universal Health Services free cash flow

National Research & Universal Health Services appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 27, 2026.